{ Health Economics }
A project isn’t a success until it moves the needle on your business
At DaVita Clinical Research (DCR) Health Economics, we don’t consider a project a success unless it has a real and measurable impact on your business. A publication or model needs to be accessible to your field force and must provide data that is meaningful and easily assimilated by your end customers.
Our team brings with it the analytic and commercial experience that only comes from having held leadership positions at the world’s largest pharmaceutical and biotechnology companies, leading the world’s largest drug and biotech franchises. We understand the data and tools necessary to support access, reimbursement, and utilization of multi-billion dollar products. We bring with us firsthand experience with FDA and EMEA filings, and drug advisory committees for reimbursement authorities including CMS and NICE. We have had numerous formulary successes for U.S.-managed care organizations through dossier submissions and P&T presentations (Wellpoint, United, Aetna, Cigna, Kaiser, etc.). We have conducted the analytics and created briefings that have helped to shape current healthcare policy.
Our products and services include:
- Economic modeling
- Epidemiology and biostatistics
- Prospective study design, execution and analysis
- Disease management design,execution and evaluation
- Psychometric developmentand validation
- Commercial reimbursementand formulary placement
- Policy analytics andlegislative briefings
- Strategic consulting
While many health economics organizations can execute a study and write publications, DCR translates the results into strategies and products, and provides you with the insight to influence your customers and grow your business.
